Determination of Dutasteride by LC: Validation and Application of the Method
暂无分享,去创建一个
[1] J. Thornhill,et al. MP-10.07: Repeat trans-rectal ultrasound (TRUS) guided prostate biopsies: our experience , 2006 .
[2] J. Isaacs,et al. Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers , 2006, Clinical Cancer Research.
[3] K. Wallner,et al. Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy. , 2006, Urology.
[4] N. Makridakis,et al. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. , 2005, Journal of molecular endocrinology.
[5] N. V. Ramakrishna,et al. Selective and rapid liquid chromatography-tandem mass spectrometry assay of dutasteride in human plasma. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] M. Karlsson,et al. Validation of a population pharmacokinetic/pharmacodynamic model for 5α-reductase inhibitors , 1999 .
[7] M. Karlsson,et al. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. , 1999, British journal of clinical pharmacology.